I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 4 studies | 16% ± 1% | |
| GABAergic neuron | 3 studies | 32% ± 3% | |
| glutamatergic neuron | 3 studies | 39% ± 5% | |
| interneuron | 3 studies | 28% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 4 studies | 16% ± 1% | |
| GABAergic neuron | 3 studies | 32% ± 3% | |
| glutamatergic neuron | 3 studies | 39% ± 5% | |
| interneuron | 3 studies | 28% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 8939.90 | 2642 / 2642 | 100% | 67.40 | 705 / 705 |
| esophagus | 100% | 3116.27 | 1445 / 1445 | 100% | 23.96 | 183 / 183 |
| prostate | 100% | 3278.57 | 245 / 245 | 100% | 32.34 | 502 / 502 |
| thymus | 100% | 4045.36 | 653 / 653 | 100% | 40.54 | 605 / 605 |
| skin | 100% | 3451.75 | 1809 / 1809 | 100% | 39.04 | 471 / 472 |
| breast | 100% | 3074.24 | 459 / 459 | 100% | 37.12 | 1114 / 1118 |
| uterus | 100% | 3313.13 | 170 / 170 | 100% | 29.80 | 457 / 459 |
| ovary | 100% | 4502.76 | 180 / 180 | 100% | 25.51 | 428 / 430 |
| kidney | 100% | 3247.64 | 89 / 89 | 99% | 34.98 | 896 / 901 |
| lung | 100% | 2536.02 | 576 / 578 | 100% | 25.69 | 1150 / 1155 |
| intestine | 100% | 3049.74 | 966 / 966 | 99% | 18.33 | 521 / 527 |
| bladder | 100% | 3380.90 | 21 / 21 | 99% | 24.48 | 498 / 504 |
| adrenal gland | 100% | 3834.36 | 258 / 258 | 99% | 44.27 | 227 / 230 |
| stomach | 99% | 2105.32 | 355 / 359 | 100% | 19.03 | 285 / 286 |
| pancreas | 91% | 1185.66 | 298 / 328 | 99% | 25.96 | 177 / 178 |
| liver | 83% | 984.68 | 187 / 226 | 95% | 15.43 | 386 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 40.26 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 25.32 | 29 / 29 |
| muscle | 100% | 4586.93 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3317.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 24.64 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.13 | 1 / 1 |
| adipose | 100% | 3073.38 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3137.07 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 2435.35 | 845 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 78% | 2123.16 | 723 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0097602 | Molecular function | cullin family protein binding |
| Gene name | KCTD2 |
| Protein name | KCTD2 protein BTB/POZ domain-containing protein KCTD2 (Potassium channel tetramerization domain-containing protein 2) Potassium channel tetramerization domain containing 2 |
| Synonyms | KIAA0176 |
| Description | |
| Accessions | ENST00000322444.7 Q14681 J3QSC8 Q8IYY2 ENST00000375286.7 H0Y3B9 ENST00000581589.5 |
